{"product_id":"fda-establishment-inspection-reports-eirs-for-scianda-pharmaceuticals-inspections-in-2015-and-2024-fei-3009853264-changshu-jiangsu-china","title":"FDA Establishment Inspection Reports (EIRs) for SciAnda Pharmaceuticals – Inspections in 2015 and 2024, FEI: 3009853264, Changshu, Jiangsu, China.","description":"\u003cb\u003eOriginal Request:\u003c\/b\u003e  Establishment Inspection Reports for the inspections held in 2015 and 2024 at the following manufacturing facility: SciAnda (Changshu) Pharmaceuticals, Ltd. No. 16 Dongzhou Road Economic Development Zone Changshu, Jiangsu, 215513 China (FEI No. 3009853264) Dates of Inspections: October 26 – 30, 2015 (Inspection ID: 951273) and March 25 – March 29, 2024 (Inspection ID: 1237197) Inspection Type: Human Drug","brand":"FDA","offers":[{"title":"Default Title","offer_id":50860941344932,"sku":"FDAFT810","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/fda-establishment-inspection-reports-eirs-for-scianda-pharmaceuticals-inspections-in-2015-and-2024-fei-3009853264-changshu-jiangsu-china","provider":"FOIA Document Source","version":"1.0","type":"link"}